ResMed Inc. logo

ResMed Inc. (RMD)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
186. 46
+3.64
+1.991%
Pre Market
$
195. 13
+8.67 +4.6498%
27.64B Market Cap
27.49 P/E Ratio
2.1% Div Yield
1.31M Volume
6.52 Eps
$ 182.82
Previous Close
Add Transaction
Day Range
184.06 190.78
Year Range
180.27 293.81
Want to track RMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Here's Why ResMed (RMD) is a Strong Value Stock

Here's Why ResMed (RMD) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs.

Investopedia | 1 year ago
3 Reasons Growth Investors Will Love ResMed (RMD)

3 Reasons Growth Investors Will Love ResMed (RMD)

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Why ResMed (RMD) is a Top Value Stock for the Long-Term

Why ResMed (RMD) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
RMD or PODD: Which Is the Better Value Stock Right Now?

RMD or PODD: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Here is Why Growth Investors Should Buy ResMed (RMD) Now

Here is Why Growth Investors Should Buy ResMed (RMD) Now

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Here's Why ResMed (RMD) is a Strong Momentum Stock

Here's Why ResMed (RMD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
RMD vs. LMAT: Which Stock Is the Better Value Option?

RMD vs. LMAT: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Loading...
Load More